Cargando…
rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
A prerequisite for using corrective gene therapy to treat humans with inherited retinal degenerative diseases that affect primarily rods is to develop viral vectors that target specifically this population of photoreceptors. The delivery of a viral vector with photoreceptor tropism coupled with a ro...
Autores principales: | Beltran, William A., Boye, Sanford L., Boye, Shannon E., Chiodo, Vince A., Lewin, Alfred S., Hauswirth, William W., Aguirre, Gustavo D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914811/ https://www.ncbi.nlm.nih.gov/pubmed/20428215 http://dx.doi.org/10.1038/gt.2010.56 |
Ejemplares similares
-
Improving retinal vascular endothelial cell tropism through rational rAAV capsid design
por: Periasamy, Ramesh, et al.
Publicado: (2023) -
Next-generation sequencing of mitochondrial targeted AAV transfer of human ND4 in mice
por: Yu, Hong, et al.
Publicado: (2013) -
Recombinant AAV-Mediated BEST1 Transfer to the Retinal Pigment Epithelium: Analysis of Serotype-Dependent Retinal Effects
por: Guziewicz, Karina E., et al.
Publicado: (2013) -
Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines
por: Ryals, Renee C., et al.
Publicado: (2011) -
PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina
por: Hickmott, Jack W, et al.
Publicado: (2016)